Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

New rubidium-82 generator efficiency improves over time

Jennifer Renaud, Matthew Wiles, Linda Garrard, Rob Beanlands and Robert DeKemp
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1045;
Jennifer Renaud
2National Cardiac PET Centre University of Ottawa Heart Institute Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Wiles
2National Cardiac PET Centre University of Ottawa Heart Institute Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Garrard
2National Cardiac PET Centre University of Ottawa Heart Institute Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob Beanlands
2National Cardiac PET Centre University of Ottawa Heart Institute Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert DeKemp
1National Cardiac PET Centre Ottawa Heart Institute Ottawa ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1045

Introduction: PET myocardial perfusion imaging (MPI) with rubidium-82 (Rb-82) is being more widely adopted due to superior diagnostic accuracy and availability without the need for an onsite cyclotron. Rb-82 is obtained by eluting a Sr-82/Rb-82 generator via an automated system, creating 82RbCl for direct patient injection. Obtaining maximal Rb-82 activity daily over several weeks extends the useful life of the generator for clinical PET imaging. We evaluated the efficiency of a commercial Rb-82 generator and elution system for delivery of activity over its lifecycle.

Methods: The efficiency of a commercial Rb-82 generator model (RUBY-FILL™, Jubilant DraxImage Inc.), used in conjunction with its partner elution system was evaluated over a 3.5-year period. An automated daily quality control (QC) procedure was performed on each day of patient use and the Rb-82 yield as measured by the onboard dose calibrator of the elution system was documented. Cumulative volume eluted through the generator was also recorded. Generator efficiency was calculated as the ratio of the daily Rb-82 yield to the theoretically expected Rb-82 activity based on the initial 100 mCi (3700 MBq) activity of the parent Sr-82 loaded onto the generator column and its radioactive decay. Efficiency was determined at installation of the generator into the elution system and at the end of each subsequent week until expiry at 8 weeks.

Results: At generator installation (1 ± 3 days after calibration), average efficiency over the 16 generators tested was determined to be 91 ± 6 %, with a maximal available activity of 80 ± 7 mCi. Generator efficiency increased over the weeks of use. Near expiry (day 52 ± 11) efficiency was significantly increased to 97 ± 7 % (p = 0.0005 as compared to installation), corresponding to a maximal available activity of 21 ± 2 mCi. This represents an overall improvement of 6% from generator installation to expiry. The increased efficiency may be due to changes in the fluid dynamics of the tin-oxide column elution profile allowing the full Rb-82 activity to be flushed off of the column after 8 weeks of use. The total eluted volume over the 8-week lifecycle was consistent for a subset of generators with this information available (N=6): 11.3 ± 0.2 L, which is well below the allowed 30 L limit. These results indicate that the daily Rb-82 activity available for elution approaches the maximum theoretical yield over time and the total eluted volume remains within allowable limits, thus extending the useful life of the generator for clinical PET MPI imaging. Conclusion: The efficiency of the RUBY-FILL™ Rb-82 generator improves over time, allowing maximal Rb-82 activity (21 mCi) to be administered for clinical PET perfusion imaging at the end of its 8-week shelf-life. Research support: Clinical trial #NCT02117284 supported by Jubilant DraxImage Inc.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New rubidium-82 generator efficiency improves over time
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
New rubidium-82 generator efficiency improves over time
Jennifer Renaud, Matthew Wiles, Linda Garrard, Rob Beanlands, Robert DeKemp
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1045;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
New rubidium-82 generator efficiency improves over time
Jennifer Renaud, Matthew Wiles, Linda Garrard, Rob Beanlands, Robert DeKemp
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1045;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Automation and Process Development Poster Session

  • Study of the relationship of preablative stimulated thyroglobulin level and the response of radioiodine treatment in non-distant-metastatic DTC patients
  • Tips and tricks gained from years of experience with GE Tracerlab FXC Pro
  • Cyclotron production of Sc-44 from natural calcium
Show more Automation and Process Development Poster Session

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire